HELEN UTOMI: Open Payments
NPI 1356772743 · CHICAGO, IL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$409 in 15 payments from 7 companies in 2025. Trend: 2023 $319 · 2024 $405 · 2025 $409
Food & beverage: $409
| Company | Payments | Amount |
|---|---|---|
| Otsuka America Pharmaceutical, Inc. | 5 | $135 |
| Alexion Pharmaceuticals, Inc. | 4 | $108 |
| Travere Therapeutics, Inc. | 2 | $40 |
| Calliditas Therapeutics US Inc. | 1 | $38 |
| Aurinia Pharma U.S., Inc. | 1 | $29 |
| GlaxoSmithKline, LLC. | 1 | $29 |
| Bayer Healthcare Pharmaceuticals Inc. | 1 | $29 |
Products named: JYNARQUE, ULTOMIRIS, TARPEYO, LUPKYNIS, BENLYSTA, Kerendia, Filspari.
Industry payments across IL — which companies pay providers there.
